BACE1 and Alzheimer disease: MiR-29c expression decreased with upregulated of BACE1 in mRNA and protein levels with elevated APPβ accumulation in sporadic AD brains; miR-29c targeted the 3′UTR of BACE1, reduced the BACE1 expression and downregulated the APPβ accumulation in vitro.